196 related articles for article (PubMed ID: 7835983)
1. Targeting of pancreatic islets of severe combined immunodeficient mice by passive transfer of allogeneic spleen cells from non-obese diabetic mice.
Reddy S; Liu W; Elliott RB
Immunol Cell Biol; 1994 Oct; 72(5):390-7. PubMed ID: 7835983
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
3. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
[TBL] [Abstract][Full Text] [Related]
4. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice.
Rohane PW; Shimada A; Kim DT; Edwards CT; Charlton B; Shultz LD; Fathman CG
Diabetes; 1995 May; 44(5):550-4. PubMed ID: 7729614
[TBL] [Abstract][Full Text] [Related]
5. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.
Ablamunits V; Elias D; Cohen IR
Clin Exp Immunol; 1999 Feb; 115(2):260-7. PubMed ID: 9933451
[TBL] [Abstract][Full Text] [Related]
6. The role of CD8+ cells, cell degeneration, and Fas ligand in insulitis after intraperitoneal transfer of NOD splenocytes.
Sainio-Pöllänen S; Liukas A; Pöllänen P; Simell O
Pancreas; 1999 Apr; 18(3):282-93. PubMed ID: 10206487
[TBL] [Abstract][Full Text] [Related]
7. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells.
Peterson JD; Haskins K
Diabetes; 1996 Mar; 45(3):328-36. PubMed ID: 8593938
[TBL] [Abstract][Full Text] [Related]
8. Beta-cell apoptosis in an accelerated model of autoimmune diabetes.
Augstein P; Stephens LA; Allison J; Elefanty AG; Ekberg M; Kay TW; Harrison LC
Mol Med; 1998 Aug; 4(8):495-501. PubMed ID: 9742505
[TBL] [Abstract][Full Text] [Related]
9. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
[TBL] [Abstract][Full Text] [Related]
10. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
Füchtenbusch M; Larger E; Thebault K; Boitard C
Horm Metab Res; 2005 Feb; 37(2):63-7. PubMed ID: 15778920
[TBL] [Abstract][Full Text] [Related]
11. Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes.
Berney T; Molano RD; Pileggi A; Cattan P; Li H; Ricordi C; Inverardi L
Transplantation; 2001 Jul; 72(1):133-40. PubMed ID: 11468548
[TBL] [Abstract][Full Text] [Related]
12. N-acetyl-cysteine accelerates transfer of diabetes into non-obese diabetic scid mice.
Irie J; Shimada A; Oikawa Y; Shigihara T; Saruta T
Diabetologia; 2004 Oct; 47(10):1803-9. PubMed ID: 15502923
[TBL] [Abstract][Full Text] [Related]
13. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
Lejon K; Fathman CG
J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
[TBL] [Abstract][Full Text] [Related]
14. The thymus as a site for evaluating the potency of candidate beta cell autoantigens in NOD mice.
Gerling IC; Atkinson MA; Leiter EH
J Autoimmun; 1994 Dec; 7(6):851-8. PubMed ID: 7888041
[TBL] [Abstract][Full Text] [Related]
15. Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.
Saï P; Senecat O; Martignat L; Gouin E
Clin Exp Immunol; 1994 Jul; 97(1):138-45. PubMed ID: 8033411
[TBL] [Abstract][Full Text] [Related]
16. CD3+ T cells in severe combined immunodeficiency (SCID) mice. V. Allogeneic T cells engrafted into SCID mice do not induce graft-versus-host disease in spite of the absence of host veto and natural suppressor cell activity.
Tscherning T; Rudolphi A; Reimann J; Claesson MH
Scand J Immunol; 1991 Dec; 34(6):795-801. PubMed ID: 1836277
[TBL] [Abstract][Full Text] [Related]
17. CD3+ T cells in severe combined immunodeficiency (scid) mice. IV. Graft-vs.-host resistance of H-2d scid mice to intravenous injection of allogeneic H-2b (C57BL/6) spleen cells.
Claesson MH; Rudolphi A; Tscherning T; Reimann J
Eur J Immunol; 1991 Sep; 21(9):2057-62. PubMed ID: 1832384
[TBL] [Abstract][Full Text] [Related]
18. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
Gerling IC; Serreze DV; Christianson SW; Leiter EH
Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
[TBL] [Abstract][Full Text] [Related]
19. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
[TBL] [Abstract][Full Text] [Related]
20. Low dose streptozotocin causes diabetes in severe combined immunodeficient (SCID) mice without immune cell infiltration of the pancreatic islets.
Reddy S; Wu D; Elliott RB
Autoimmunity; 1995; 20(2):83-92. PubMed ID: 7578872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
